Aptose Biosciences Inc. (APTO): Bagan tingkat prakiraan

Simbol lan logo merek Aptose (APTO)

Demand for new leukemia therapies remains colossal, yet geopolitical tensions and raw material logistics risks create certain barriers for the biotech sector. Market fluctuations in Aptose Biosciences Inc. (APTO) share prices on GURU.Markets, where the consensus stands at 12.54, reflect the dynamics of a company developing a unique targeted delivery system for blood tumors to save patients in critical condition.

APTO - Bagan rega target Aptose Biosciences Inc. ing rentang 04.07.2022 - 13.04.2025

Rincian analitis perusahaan Aptose Biosciences Inc. (APTO)

Indikator analitis utama aptose.com (APTO):
Rega saham aptose.com|APTO - Bagan rega target|Biji pasar Aptose
Analisis fundamental perusahaan:Aptose Biosciences Inc (APTO)
Produk asli Aptose Biosciences Inc.

This indicator represents the weighted average expected share value, reflecting the mathematical smoothing of investment bank forecasts and the tendency of experts to lag in adapting to market rallies. For Aptose Biosciences Inc. (APTO), the market consensus benchmark remains stable due to the humanitarian status of biomedicine and low geopolitical risks, allowing investors to distinguish speculative price spikes from the actual resilience of the business.

Perusahaan pesaing

Prakiraan konsensus analis tgtherapeutics.com (TGTX)|Bagan rega target Arcellx, Inc. ACLX|IRON (Disc Medicine Inc) - Bagan tingkat prakiraan|SNDX: Target konsensus|Kura - Rega prakiraan analis|ADC Therapeutics (ADCT) - Bagan rega target|Rata-rata rega prakiraan Foghorn Therapeutics Inc. (FHTX)|VOR (Vor Biopharma) - Prakiraan konsensus analis|Target konsensus Nkarta Corp (NKTX)|Prakiraan konsensus analis COEP|Prakiraan konsensus analis Actinium Corp (ATNM)|Bagan rega target Estrella Immunopharma ESLA|CASI: Prakiraan gabungan firma investasi|Marker Bio - Prakiraan konsensus analis|IN8bio Inc. (INAB) - Target konsensus|ERNA: Prakiraan konsensus analis|Rata-rata rega prakiraan GT Biopharma Corporation (GTBP)|Bagan rega target Bio-Path Holdings|MEIP: Konsensus nilai wajar|Target konsensus VINC (Vincerx Pharma, Inc.)